Month: <span>September 2024</span>

Home / 2024 / September
Polycystic ovary syndrome linked to increased odds of eating disorders
Post

Polycystic ovary syndrome linked to increased odds of eating disorders

August 17, 2024 by Elana Gotkine Polycystic ovary syndrome (PCOS) is associated with an increased likelihood of any eating disorder, according to a review published online Aug. 8 in the Journal of Clinical Endocrinology & Metabolism. Laura G. Cooney, M.D., from the University of Wisconsin in Madison, and colleagues conducted a systematic review and meta-analysis...

Post

No HIV Infections After Twice-a-Year PrEP

Medscape Medical News Brian Owens July 05, 2024 Lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, has shown 100% efficacy in preventing HIV in women at a high risk for infection, according to an interim analysis of the phase 3 PURPOSE 1 trial. The results were so promising that the independent data monitoring committee recommended that...

5th human case of flea-borne typhus reported in Orange County
Post

5th human case of flea-borne typhus reported in Orange County

By David González Thursday, August 15, 2024 6:34PM Orange County’s fifth human case of flea-borne typhus has been reported in Fountain Valley.FOUNTAIN VALLEY, Calif. (KABC) — Public health advisories have been posted near the intersection of Slater Avenue and Magnolia Street in Fountain Valley after a case of flea-borne typhus was detected in the area.“Most...

Nutritional Psychiatry: Does It Exist?
Post

Nutritional Psychiatry: Does It Exist?

Perspective > MDedgeCOMMENTARY Andrew J. Rosenfeld, MD Disclosures August 25, 2023 Matt was diagnosed with ADHD combined type when he was 6 years old. Given his age, the family was reluctant to try medications, but after a couple years of parenting classes and reward charts, the parents requested a stimulant. He had significant improvement in...

Post

FDA approves Nemluvio for prurigo nodularis

August 16, 2024 The U.S. Food and Drug Administration has approved Galderma’s Nemluvio (nemolizumab) for adult patients living with prurigo nodularis. Nemluvio, administered as a prefilled pen for subcutaneous injection, inhibits interleukin-31 cytokine signaling, which is known to drive itch and is involved in inflammation, altered epidermal differentiation, and fibrosis in prurigo nodularis. The approval...

Post

Data show overall ED visit rate 47 visits per 100 people in 2022

August 16, 2024 by Elana Gotkine In 2022, the emergency department visit rate was 47 visits per 100 people, according to an August data brief published by the National Center for Health Statistics. Christopher Cairns, M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from the 2022 National Hospital...

Post

BRCA Mutations in Men: Important but Often Overlooked

Medscape Medical News Megan Brooks August 14, 2024 BRCA1 and BRCA2 pathogenic variants carry well-known associations with breast and ovarian cancers in women, which has led to robust clinical guidelines for early genetic testing and risk-reduction strategies. Male carriers of BRCA1/2 pathogenic variants also face an increased risk for cancer, particularly of the prostate, pancreas,...

WHO has declared mpox a global health emergency. What happens next?
Post

WHO has declared mpox a global health emergency. What happens next?

August 15, 2024 by C Raina MacIntyre, The Conversation Credit: CC0 Public DomainThe World Health Organization (WHO) has declared mpox a public health emergency of international concern, after rising cases in the Democratic Republic of the Congo and the potential for further spread. This now triggers a coordinated international response to an extraordinary event and...

Post

Organ Damage More Common in Early Stages of Lupus

MEDBRIEF Edited by Manasi Talwadekar August 12, 2024 TOPLINE:The first year after the diagnosis of systemic lupus erythematosus (SLE) is crucial, with the highest percentage of patients experiencing organ damage. Cardiovascular issues are the second most prevalent after musculoskeletal damage in both early and later stages of SLE. METHODOLOGY:Researchers assessed organ damage persisting at least...

Post

Sexual Arousal Cream Promising in Some Subsets of Women

MDedge News Marcia Frellick August 14, 2024 Topical sildenafil (citrate) cream 3.6% used by healthy premenopausal women with a primary symptom of female sexual arousal disorder did not show statistically significant improvement over placebo in the coprimary or secondary endpoints over a 3-month period in new preliminary study data published in Obstetrics & Gynecology. Topical...